Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Scandinavian Journal of Urology and Nephrology
|
November 15, 2011
Predictive factors for urinary retention following kidney transplantation in male patients
C Gratzke, A Pahde, M Dickmann, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
January 26, 2012
Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment
J Scheidler, I Weöres, C Brinkschmidt, et al.
European Journal of Medical Research
|
December 17, 2008
Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib
Michael Staehler, N Haseke, G Schöppler, et al.
European Journal of Medical Research
|
August 11, 2010
Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation
Michael Staehler, N Haseke, A Roosen, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
January 1, 1996
Immune reactions induced by interleukin-2 transfected colorectal cancer cells in vitro: predominant induction of lymphokine-activated killer cells
M Lindauer, H K Schackert, J Gebert, et al.
Cytokines and Molecular Therapy
|
September 1, 1995
CD80-transfected human breast and ovarian tumor cell lines: improved immunogenicity and induction of cytolytic CD8+ T lymphocytes
B Gückel, M Lindauer, W Rudy, et al.
World Journal of Urology
|
June 1, 2010
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
M Siebels, K Rohrmann, R Oberneder, et al.
The Journal of Urology
|
October 5, 2001
Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection
D Zaak, D Frimberger, H Stepp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 7, 2002
Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma
R J Motzer, A Rakhit, J Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2004
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
J Atzpodien, H Kirchner, U Jonas, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Scandinavian Journal of Urology and Nephrology
|
November 15, 2011
Predictive factors for urinary retention following kidney transplantation in male patients
C Gratzke, A Pahde, M Dickmann, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin
|
January 26, 2012
Diagnosis of prostate cancer in patients with persistently elevated PSA and tumor-negative biopsy in ambulatory care: performance of MR imaging in a multi-reader environment
J Scheidler, I Weöres, C Brinkschmidt, et al.
European Journal of Medical Research
|
December 17, 2008
Carcinoma of the collecting ducts of Bellini of the kidney: adjuvant chemotherapy followed by multikinase-inhibition with sunitinib
Michael Staehler, N Haseke, G Schöppler, et al.
European Journal of Medical Research
|
August 11, 2010
Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation
Michael Staehler, N Haseke, A Roosen, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
January 1, 1996
Immune reactions induced by interleukin-2 transfected colorectal cancer cells in vitro: predominant induction of lymphokine-activated killer cells
M Lindauer, H K Schackert, J Gebert, et al.
Cytokines and Molecular Therapy
|
September 1, 1995
CD80-transfected human breast and ovarian tumor cell lines: improved immunogenicity and induction of cytolytic CD8+ T lymphocytes
B Gückel, M Lindauer, W Rudy, et al.
World Journal of Urology
|
June 1, 2010
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
M Siebels, K Rohrmann, R Oberneder, et al.
The Journal of Urology
|
October 5, 2001
Quantification of 5-aminolevulinic acid induced fluorescence improves the specificity of bladder cancer detection
D Zaak, D Frimberger, H Stepp, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 7, 2002
Phase II trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma
R J Motzer, A Rakhit, J Thompson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 26, 2004
Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
J Atzpodien, H Kirchner, U Jonas, et al.
Page
of 5